- Home
- GTIM vs ENLV Comparison
GTIM vs ENLV Comparison
Compare GTIM & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTIM
- ENLV
- Stock Information
- Founded
- GTIM 1987
- ENLV 2005
- Country
- GTIM United States
- ENLV Israel
- Employees
- GTIM N/A
- ENLV N/A
- Industry
- GTIM Restaurants
- ENLV Biotechnology: Pharmaceutical Preparations
- Sector
- GTIM Consumer Discretionary
- ENLV Health Care
- Exchange
- GTIM Nasdaq
- ENLV Nasdaq
- Market Cap
- GTIM 28.9M
- ENLV 27.3M
- IPO Year
- GTIM 1990
- ENLV 1995
- Fundamental
- Price
- GTIM $2.51
- ENLV $1.24
- Analyst Decision
- GTIM
- ENLV Strong Buy
- Analyst Count
- GTIM 0
- ENLV 2
- Target Price
- GTIM N/A
- ENLV $9.50
- AVG Volume (30 Days)
- GTIM 15.7K
- ENLV 434.6K
- Earning Date
- GTIM 12-12-2024
- ENLV 11-29-2024
- Dividend Yield
- GTIM N/A
- ENLV N/A
- EPS Growth
- GTIM N/A
- ENLV N/A
- EPS
- GTIM 0.14
- ENLV N/A
- Revenue
- GTIM $142,315,000.00
- ENLV N/A
- Revenue This Year
- GTIM N/A
- ENLV N/A
- Revenue Next Year
- GTIM N/A
- ENLV N/A
- P/E Ratio
- GTIM $17.93
- ENLV N/A
- Revenue Growth
- GTIM 3.01
- ENLV N/A
- 52 Week Low
- GTIM $2.18
- ENLV $0.81
- 52 Week High
- GTIM $3.45
- ENLV $4.59
- Technical
- Relative Strength Index (RSI)
- GTIM 37.61
- ENLV 53.08
- Support Level
- GTIM $2.50
- ENLV $1.16
- Resistance Level
- GTIM $2.59
- ENLV $1.24
- Average True Range (ATR)
- GTIM 0.12
- ENLV 0.10
- MACD
- GTIM -0.02
- ENLV 0.01
- Stochastic Oscillator
- GTIM 22.02
- ENLV 56.68
About GTIM Good Times Restaurants Inc.
Good Times Restaurants Inc is engaged in developing, owning, operating, and franchising hamburger-oriented drive-through restaurants. It operates through two segments: Good Times Burgers and Frozen Custard restaurants which operate in the quick-service drive-through dining industry; and Bad Daddy's Burger Bar restaurants which operate in the full-service upscale casual dining industry. The company generates maximum revenue from the Bad Daddy's Burger Bar restaurants segment. Its menu categories include burgers; chicken; kids; breakfast; frozen custard; slides and drinks.
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.